ALK and non-small cell lung carcinoma: As shown in Table 4, the PPV for the 3 microRNAs was higher than 80%, which indicated that a non-small cell lung cancer patient with low plasma levels of any 1 of the 3 microRNAs was more likely to have ALK-positive disease compared with a patient with high plasma levels of the 3 microRNAs.